OverviewChartNewsTraderScreen

Erste Bank Knock-Out FACC/  AT0000A3CAQ6  /

Stuttgart
03/06/2024  09:17:08 Chg.+0.003 Bid11:19:18 Ask11:19:18 Underlying Strike price Expiration date Option type
0.219EUR +1.39% 0.209
Bid Size: 10,000		 0.229
Ask Size: 10,000		 FACC AG INH.AKT. 4.8955 - 31/12/2078 Call
GlobeNewswire 17/05 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
GlobeNewswire 17/05 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...
GlobeNewswire 16/05 CVRx Announces Key Senior Leadership Team Hires
GlobeNewswire 15/05 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire 15/05 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...
GlobeNewswire 07/05 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...
GlobeNewswire 07/05 Rugby Provides Exploration Update on its Gold-Silver Projects in  Santa Cruz Province, Argentina
GlobeNewswire 02/05 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...
GlobeNewswire 30/04 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire 23/04 Clinical ink announces GlucoseReady™
GlobeNewswire 08/04 Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire 07/04 Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire 01/04 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire 27/03 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire 25/03 Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire 25/03 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire 13/03 Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire 12/03 HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire 27/02 Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire 26/02 HeartSciences Adds Key Advisor to its Scientific Advisory Board
GlobeNewswire 22/02 RAJANT HEALTH’S CUTTING-EDGE WEARABLE RECEIVES MEDICAL EXPERT ENDORSEMENTS
GlobeNewswire 20/02 Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...
GlobeNewswire 09/02 Inteleos Announces 2024 Board of Directors
GlobeNewswire 07/02 Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...
GlobeNewswire 29/01 Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...